Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 2/20 | 0.58 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.50 |
| ▸ | BCHE | P06276 | 2/20 | 0.45 |
| ▸ | ACHE | P22303 | 1/20 | 0.45 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.41 |
| ▸ | MTOR | P42345 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | TACR2 | P21452 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27303564 | 1.00 | SLC6A2 (0.58) | SLC6A2PDE4DBCHEACHEPDPK1 | |
| SCHEMBL30039527 | 1.00 | SLC6A2 (0.58) | SLC6A2PDE4DBCHEACHEPDPK1 | |
| SCHEMBL22710225 | 1.00 | SLC6A2 (0.58) | SLC6A2PDE4DBCHEACHEPDPK1 | |
| SCHEMBL20193189 | 1.00 | SLC6A2 (0.58) | SLC6A2PDE4DBCHEACHEPDPK1 | |
| SCHEMBL20107393 | 1.00 | SLC6A2 (0.58) | SLC6A2PDE4DBCHEACHEPDPK1 | |
| SCHEMBL8717719 | 0.92 | SLC6A2 (0.54) | SLC6A2PDE4DBCHEACHECYP2C19 | |
| SCHEMBL20843083 | 0.89 | SLC6A2 (0.53) | SLC6A2PDE4DBCHEACHETSHR | |
| SCHEMBL19145004 | 0.89 | SLC6A2 (0.69) | SLC6A2PDE4DBCHEACHEPDPK1 | |
| SCHEMBL9008118 | 0.87 | SLC6A2 (0.50) | SLC6A2PDE4DBCHEACHETSHR | |
| SCHEMBL17012295 | 0.87 | SLC6A2 (0.47) | SLC6A2PDE4DBCHEACHEPDPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023288015-A1 | M6PR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES | LYCIA THERAPEUTICS, INC. (US) | 2023-01-19 | — | — | WO | disclosed |